Business Standard

Blackstone, Baring in race to acquire up to 20% stake in pharma firm Cipla

Cipla shares closed 9.6 per cent up on Thursday to Rs. 1,175

Cipla
Premium

Dev ChatterjeeSohini Das Mumbai

Listen to This Article

In one of the largest potential transactions this year, private-equity majors Blackstone and Baring have initiated talks with the Hamied family, the promoters of pharmaceutical firm Cipla, to acquire up to 20 per cent in the company.
 
The family owns 33.47 per cent and may become minority owners if the talks succeed, said a source close to the development.
It has appointed bankers to seek bids from potential investors, and Blackstone and Baring PE have responded.
“There is 15-20 per cent which is on the block by the family and a decision is expected soon,” said the source, asking not to be

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in